St Andrews Research Repository

St Andrews University Home
View Item 
  •   St Andrews Research Repository
  • Biology (School of)
  • Biology
  • Biology Theses
  • View Item
  •   St Andrews Research Repository
  • Biology (School of)
  • Biology
  • Biology Theses
  • View Item
  •   St Andrews Research Repository
  • Biology (School of)
  • Biology
  • Biology Theses
  • View Item
  • Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

Title redacted

Thumbnail
View/Open
RossCoronPhDThesis.pdf (60.78Mb)
Date
2016
Author
Coron, Ross P.
Supervisor
Smith, Terry K.
Metadata
Show full item record
Altmetrics Handle Statistics
Abstract
The neglected tropical disease, American Trypanosomiasis (also known as Chagas’ disease) is the most important parasitic infection in Latin America, and the most lethal endemic infectious disease in the Western Hemisphere. 8‐9 million individuals are currently infected with the disease, and a further 25 million are at risk. Currently available chemotherapies approved for the treatment of Chagas’ disease are ageing, ineffective, and exhibit severe side effects ‐ new treatments are urgently required. One possible drug target against Trypanosoma cruzi ‐ the protozoan etiological agent of Chagas’ disease ‐ is the biosynthesis of the parasitic glycosylphosphatidylinositol (GPI) anchor and GPI‐related molecules such as glycosylinositolphospholipids (GIPLs), which dominate the organism’s cell surface. Despite structural variations, these complex structures are ubiquitously decorated with an unusual (2‐aminoethyl) phosphonate (AEP) moiety on the O‐6 of glucosamine in the GPI core motif, and is hypothesized to play a role in both host‐infection and parasitic persistence. Entirely absent in higher eukaryotes ‐ including humans ‐ a greater understanding of the Trypanosoma cruzi AEP biosynthetic / biodegradative pathway may allow for the development of novel, parasite‐specific chemotherapeutics. This study determined the essentiality of the T. cruzi AEP biosynthetic / biodegradative pathway through both chemical and genetic methodologies, including a classical two‐ step gene replacement and ectopic reintroduction strategy. Validation was provided through both qRT‐PCR and Southern blot analysis. The resulting genetically modified cell‐line phenotypes were extensively described through a number of techniques including: cell growth studies, radiolabelling experiments, gas chromatography mass‐spectrometry (GC‐MS), multiple reaction monitoring mass‐spectrometry (MRM), and lipidomic analysis. Furthermore, the three enzymes of the poorly characterised T. cruzi AEP biosynthetic pathway (i.e. phosphoenolpyruvate mutase, phosphonopyruvate decarboxylase, and (2‐aminoethyl)phosphonate transaminase) were recombinantly expressed and purified for characterization through a series of biochemical assays. Immunofluorescence microscopy studies additionally were performed to determine the subcellular localization of these enzymes. Significant progress was also made in generating a crystal structure of the T. cruzi PEP mutase enzyme, whilst in silico modeling efforts provided catalytic insights into the TcAEP pathway enzymes in the interim. An interrogation of the T. cruzi genome provided evidence that the parasite does not encode for phosphonoacetaldehyde hydrolase (phosphonatase) ‐ an enzyme present in a number of other organisms capable of AEP biosynthesis. High throughput screening of compounds by differential scanning fluorimetry (DSF) was additionally performed against the T. cruzi AEP transaminase. Putative hits were further screened against T. cruzi epimastigotes in vivo. These efforts identified a number of fragments with EC₅₀ values in‐line with the current frontline treatment against Chagas’ disease. Finally, this body of work also reported the putative identification of a novel, high‐energy donor of AEP, and other AEP‐containing metabolites through both lipidomic and mass‐spectrometric techniques.
Type
Thesis, PhD Doctor of Philosophy
Collections
  • Biology Theses
URI
http://hdl.handle.net/10023/15689

Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

Advanced Search

Browse

All of RepositoryCommunities & CollectionsBy Issue DateNamesTitlesSubjectsClassificationTypeFunderThis CollectionBy Issue DateNamesTitlesSubjectsClassificationTypeFunder

My Account

Login

Open Access

To find out how you can benefit from open access to research, see our library web pages and Open Access blog. For open access help contact: openaccess@st-andrews.ac.uk.

Accessibility

Read our Accessibility statement.

How to submit research papers

The full text of research papers can be submitted to the repository via Pure, the University's research information system. For help see our guide: How to deposit in Pure.

Electronic thesis deposit

Help with deposit.

Repository help

For repository help contact: Digital-Repository@st-andrews.ac.uk.

Give Feedback

Cookie policy

This site may use cookies. Please see Terms and Conditions.

Usage statistics

COUNTER-compliant statistics on downloads from the repository are available from the IRUS-UK Service. Contact us for information.

© University of St Andrews Library

University of St Andrews is a charity registered in Scotland, No SC013532.

  • Facebook
  • Twitter